197 related articles for article (PubMed ID: 7911318)
1. Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Lymphoma Working Party of the EBMT.
Liberti G; Pearce R; Taghipour G; Majolino I; Goldstone AH
Ann Oncol; 1994; 5 Suppl 2():151-3. PubMed ID: 7911318
[TBL] [Abstract][Full Text] [Related]
2. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Majolino I; Pearce R; Taghipour G; Goldstone AH
J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
[TBL] [Abstract][Full Text] [Related]
3. High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
Brunvand MW; Bensinger WI; Soll E; Weaver CH; Rowley SD; Appelbaum FR; Lilleby K; Clift RA; Gooley TA; Press OW; Fefer A; Storb R; Sanders JE; Martin PL; Chauncey T; Maziarz RT; Zuckerman N; Montgomery P; Dorn R; Weiden PL; Demirer T; Holmberg LA; Schiffman K; McSweeney PA; Buckner CD
Bone Marrow Transplant; 1996 Jul; 18(1):131-41. PubMed ID: 8832006
[TBL] [Abstract][Full Text] [Related]
4. Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.
Vose JM; Sharp G; Chan WC; Nichols C; Loh K; Inwards D; Rifkin R; Bierman PJ; Lynch JC; Weisenburger DD; Kessinger A; Armitage JO
J Clin Oncol; 2002 May; 20(9):2344-52. PubMed ID: 11981006
[TBL] [Abstract][Full Text] [Related]
5. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
6. Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry.
Williams CD; Goldstone AH; Pearce RM; Philip T; Hartmann O; Colombat P; Santini G; Foulard L; Gorin NC
J Clin Oncol; 1996 Sep; 14(9):2454-64. PubMed ID: 8823323
[TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry.
Williams CD; Pearce R; Taghipour G; Green ES; Philip T; Goldstone AH
J Clin Oncol; 1994 Nov; 12(11):2415-22. PubMed ID: 7964958
[TBL] [Abstract][Full Text] [Related]
8. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
[TBL] [Abstract][Full Text] [Related]
9. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
[TBL] [Abstract][Full Text] [Related]
10. Comparison of interferon tolerance after autologous bone marrow or peripheral blood stem cell transplants for myeloma patients who have responded to induction therapy.
Powles R; Raje N; Horton C; Mehta J; Singhal S; Hickish T; Viner C; Milan S; Treleaven J; Cunningham D
Leuk Lymphoma; 1996 May; 21(5-6):421-7. PubMed ID: 9172806
[TBL] [Abstract][Full Text] [Related]
11. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data.
Chopra R; Goldstone AH; Pearce R; Philip T; Petersen F; Appelbaum F; De Vol E; Ernst P
J Clin Oncol; 1992 Nov; 10(11):1690-5. PubMed ID: 1403052
[TBL] [Abstract][Full Text] [Related]
12. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
13. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
14. [Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor].
Endo M; Tanosaki R
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1762-70. PubMed ID: 7574807
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.
Milpied N; Fielding AK; Pearce RM; Ernst P; Goldstone AH
J Clin Oncol; 1996 Apr; 14(4):1291-6. PubMed ID: 8648386
[TBL] [Abstract][Full Text] [Related]
17. Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma.
Raje N; Powles R; Horton C; Millar B; Shepherd V; Middleton G; Kulkarni S; Eisen T; Mehta J; Singhal S; Treleaven J
Br J Cancer; 1997; 75(11):1684-9. PubMed ID: 9184187
[TBL] [Abstract][Full Text] [Related]
18. Role of a second transplant in the management of poor-prognosis lymphomas: a report from the European Blood and Bone Marrow Registry.
Vandenberghe E; Pearce R; Taghipour G; Fouillard L; Goldstone AH
J Clin Oncol; 1997 Apr; 15(4):1595-600. PubMed ID: 9193358
[TBL] [Abstract][Full Text] [Related]
19. [Autologous peripheral blood stem cell transplantation combined with autologous bone marrow transplantation for treating refractory lymphoma].
Chen XL; Su H; Zhong KL; DA Y; Xiao XB; Liu J; Yu JD; Zhang WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):155-9. PubMed ID: 19236769
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
